methadone has been researched along with Co-infection in 18 studies
Methadone: A synthetic opioid that is used as the hydrochloride. It is an opioid analgesic that is primarily a mu-opioid agonist. It has actions and uses similar to those of MORPHINE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1082-3)
methadone : A racemate comprising equimolar amounts of dextromethadone and levomethadone. It is a opioid analgesic which is used as a painkiller and as a substitute for heroin in the treatment of heroin addiction.
6-(dimethylamino)-4,4-diphenylheptan-3-one : A ketone that is heptan-3-one substituted by a dimethylamino group at position 6 and two phenyl groups at position 4.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess trends and related factors in HIV and/or hepatitis C virus (HCV) antibody testing and infection among injection drug users (IDUs) newly entering methadone maintenance treatment (MMT) in Guangdong Province, China." | 7.85 | Trends and factors in human immunodeficiency virus and/or hepatitis C virus testing and infection among injection drug users newly entering methadone maintenance treatment in Guangdong Province, China 2006-2013: a consecutive cross sectional study. ( Chen, W; Ling, L; Liu, Y; Zou, X, 2017) |
| "The aim of this study was to characterize the epidemiology and disease related to hepatitis C in a population attending a low-threshold methadone program." | 7.85 | Hepatitis C in a Mobile Low-Threshold Methadone Program. ( Água-Doce, I; Balsa, C; Belo, E; Coutinho, R; Lopes, P; Loureiro, R; Martins, HC; Pádua, E; Pereira, C; Silva, MJ, 2017) |
| "Methadone treatment (exposure) was self-reported and severe FI (outcome) was measured using the Household Food Security Survey Module." | 5.48 | Methadone treatment, severe food insecurity, and HIV-HCV co-infection: A propensity score matching analysis. ( Cooper, C; Cox, J; Hamelin, AM; Harper, S; Klein, MB; McLinden, T; Moodie, EEM; Rossi, C; Rourke, SB; Walmsley, SL, 2018) |
| "A methadone maintenance treatment (MMT) program to curb the dual epidemics of HIV/AIDS and drug use has been administered by China since 2004." | 5.46 | Spatial distribution of HIV, HCV, and co-infections among drug users in the southwestern border areas of China (2004-2014): a cohort study of a national methadone maintenance treatment program. ( He, C; Huang, W; Lan, G; Li, C; Li, M; Li, R; Liang, N; Peng, Z; Shen, Z; Tang, X; Zhong, F, 2017) |
| "The diagnosis of pulmonary tuberculosis associated with Kaposi's sarcoma and immunosuppression caused by HIV was retained." | 5.46 | [TB/HIV co-infection associated with Kaposi's sarcoma under opioid substitution treatment using methadone: about a case]. ( Cisse Diallo, VMP; Deguenonvo, LF; Dièye, A; Diop Nyafouna, SA; Diop, M; Ka, D; Lakhe, NA; Massaly, A; Mbaye, KD; Ndiaye, I; Ndour, CT; Seydi, M; Thioub, D, 2017) |
| "Patients with opioid use disorders on opioid agonist therapy (OAT) have lower pain tolerance compared to controls." | 5.42 | Hepatitis C virus infection and pain sensitivity in patients on methadone or buprenorphine maintenance therapy for opioid use disorders. ( Alford, DP; Cheng, DM; Edwards, RR; Liebschutz, JM; Lira, MC; Mao, J; Samet, JH; Tsui, JI; Winter, MR, 2015) |
| "Methadone maintenance treatment (MMT) has been available in Guangdong province, China since 2006." | 5.39 | High prevalence of HIV, HCV and tuberculosis and associated risk behaviours among new entrants of methadone maintenance treatment clinics in Guangdong Province, China. ( Chen, W; Ling, L; Zhang, D; Zhang, L; Zou, X, 2013) |
| "To assess trends and related factors in HIV and/or hepatitis C virus (HCV) antibody testing and infection among injection drug users (IDUs) newly entering methadone maintenance treatment (MMT) in Guangdong Province, China." | 3.85 | Trends and factors in human immunodeficiency virus and/or hepatitis C virus testing and infection among injection drug users newly entering methadone maintenance treatment in Guangdong Province, China 2006-2013: a consecutive cross sectional study. ( Chen, W; Ling, L; Liu, Y; Zou, X, 2017) |
| "The aim of this study was to characterize the epidemiology and disease related to hepatitis C in a population attending a low-threshold methadone program." | 3.85 | Hepatitis C in a Mobile Low-Threshold Methadone Program. ( Água-Doce, I; Balsa, C; Belo, E; Coutinho, R; Lopes, P; Loureiro, R; Martins, HC; Pádua, E; Pereira, C; Silva, MJ, 2017) |
| "To describe potential drug-drug interactions in the area of HIV/hepatitis C virus (HCV) coinfection and injection drug use, including those between antiretrovirals (ARVs), direct-acting antivirals (DAAs), and opioid-agonist therapy, and to supply a practical approach to their management." | 2.52 | Drug-Drug Interactions With Antiviral Agents in People Who Inject Drugs Requiring Substitution Therapy. ( Christensen, S; Gillessen, A; Hanhoff, N; Meemken, L; Tseng, A, 2015) |
| "Methadone maintenance treatment (MMT) was implemented in China since 2004." | 2.48 | HIV and HCV prevalence among entrants to methadone maintenance treatment clinics in China: a systematic review and meta-analysis. ( Chow, EP; Liang, Y; Wang, Y; Wilson, DP; Zhang, L; Zhuang, X, 2012) |
| "Methadone treatment (exposure) was self-reported and severe FI (outcome) was measured using the Household Food Security Survey Module." | 1.48 | Methadone treatment, severe food insecurity, and HIV-HCV co-infection: A propensity score matching analysis. ( Cooper, C; Cox, J; Hamelin, AM; Harper, S; Klein, MB; McLinden, T; Moodie, EEM; Rossi, C; Rourke, SB; Walmsley, SL, 2018) |
| "A methadone maintenance treatment (MMT) program to curb the dual epidemics of HIV/AIDS and drug use has been administered by China since 2004." | 1.46 | Spatial distribution of HIV, HCV, and co-infections among drug users in the southwestern border areas of China (2004-2014): a cohort study of a national methadone maintenance treatment program. ( He, C; Huang, W; Lan, G; Li, C; Li, M; Li, R; Liang, N; Peng, Z; Shen, Z; Tang, X; Zhong, F, 2017) |
| "The diagnosis of pulmonary tuberculosis associated with Kaposi's sarcoma and immunosuppression caused by HIV was retained." | 1.46 | [TB/HIV co-infection associated with Kaposi's sarcoma under opioid substitution treatment using methadone: about a case]. ( Cisse Diallo, VMP; Deguenonvo, LF; Dièye, A; Diop Nyafouna, SA; Diop, M; Ka, D; Lakhe, NA; Massaly, A; Mbaye, KD; Ndiaye, I; Ndour, CT; Seydi, M; Thioub, D, 2017) |
| "Patients with opioid use disorders on opioid agonist therapy (OAT) have lower pain tolerance compared to controls." | 1.42 | Hepatitis C virus infection and pain sensitivity in patients on methadone or buprenorphine maintenance therapy for opioid use disorders. ( Alford, DP; Cheng, DM; Edwards, RR; Liebschutz, JM; Lira, MC; Mao, J; Samet, JH; Tsui, JI; Winter, MR, 2015) |
| "Methadone maintenance treatment (MMT) has been available in Guangdong province, China since 2006." | 1.39 | High prevalence of HIV, HCV and tuberculosis and associated risk behaviours among new entrants of methadone maintenance treatment clinics in Guangdong Province, China. ( Chen, W; Ling, L; Zhang, D; Zhang, L; Zou, X, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 17 (94.44) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Pes, F | 1 |
| Onali, S | 1 |
| Balestrieri, C | 1 |
| Angioni, G | 1 |
| Ortu, F | 1 |
| Piano, P | 1 |
| Lucia, B | 1 |
| Scioscia, R | 1 |
| Princic, E | 1 |
| Bolliri, AC | 1 |
| Casale, M | 1 |
| Cola, A | 1 |
| Conti, M | 1 |
| Peddis, L | 1 |
| Serra, G | 1 |
| Vacca, S | 1 |
| Loi, M | 1 |
| Urru, E | 1 |
| Murru, C | 1 |
| Matta, L | 1 |
| Del Giacco, S | 1 |
| Babudieri, S | 1 |
| Maida, I | 1 |
| Chessa, L | 1 |
| Roncero, C | 1 |
| Fuster, D | 1 |
| Palma-Álvarez, RF | 1 |
| Rodriguez-Cintas, L | 1 |
| Martinez-Luna, N | 1 |
| Álvarez, FJ | 1 |
| Liu, Y | 2 |
| Zou, X | 2 |
| Chen, W | 2 |
| Ling, L | 2 |
| Li, M | 1 |
| Li, R | 1 |
| Shen, Z | 1 |
| Li, C | 1 |
| Liang, N | 1 |
| Peng, Z | 1 |
| Huang, W | 1 |
| He, C | 1 |
| Zhong, F | 1 |
| Tang, X | 1 |
| Lan, G | 1 |
| Cisse Diallo, VMP | 1 |
| Deguenonvo, LF | 1 |
| Mbaye, KD | 1 |
| Ka, D | 1 |
| Lakhe, NA | 1 |
| Ndiaye, I | 1 |
| Thioub, D | 1 |
| Diop Nyafouna, SA | 1 |
| Massaly, A | 1 |
| Dièye, A | 1 |
| Diop, M | 1 |
| Ndour, CT | 1 |
| Seydi, M | 1 |
| Schackman, BR | 1 |
| Gutkind, S | 1 |
| Morgan, JR | 1 |
| Leff, JA | 1 |
| Behrends, CN | 1 |
| Delucchi, KL | 1 |
| McKnight, C | 1 |
| Perlman, DC | 1 |
| Masson, CL | 1 |
| Linas, BP | 1 |
| McLinden, T | 1 |
| Moodie, EEM | 1 |
| Hamelin, AM | 1 |
| Harper, S | 1 |
| Rossi, C | 1 |
| Walmsley, SL | 1 |
| Rourke, SB | 1 |
| Cooper, C | 1 |
| Klein, MB | 1 |
| Cox, J | 1 |
| Yi, S | 1 |
| Mun, P | 1 |
| Chhoun, P | 1 |
| Chann, N | 1 |
| Tuot, S | 1 |
| Mburu, G | 1 |
| Zhang, L | 2 |
| Zhang, D | 1 |
| Marco, A | 1 |
| Gallego, C | 1 |
| Caylà, JA | 1 |
| Zhou, YB | 1 |
| Liang, S | 1 |
| Wang, QX | 1 |
| Gong, YH | 1 |
| Nie, SJ | 1 |
| Nan, L | 1 |
| Yang, AH | 1 |
| Liao, Q | 1 |
| Song, XX | 1 |
| Jiang, QW | 1 |
| Meemken, L | 1 |
| Hanhoff, N | 1 |
| Tseng, A | 1 |
| Christensen, S | 1 |
| Gillessen, A | 1 |
| Tsui, JI | 1 |
| Lira, MC | 1 |
| Cheng, DM | 1 |
| Winter, MR | 1 |
| Alford, DP | 1 |
| Liebschutz, JM | 1 |
| Mao, J | 1 |
| Edwards, RR | 1 |
| Samet, JH | 1 |
| Gervasoni, C | 1 |
| Peri, AM | 1 |
| Cattaneo, D | 1 |
| Baldelli, S | 1 |
| Rizzardini, G | 1 |
| Milazzo, L | 1 |
| Pu, L | 1 |
| Su, Y | 1 |
| Wang, G | 1 |
| Bai, J | 1 |
| Silva, MJ | 1 |
| Pereira, C | 1 |
| Loureiro, R | 1 |
| Balsa, C | 1 |
| Lopes, P | 1 |
| Água-Doce, I | 1 |
| Belo, E | 1 |
| Martins, HC | 1 |
| Coutinho, R | 1 |
| Pádua, E | 1 |
| Zhuang, X | 1 |
| Liang, Y | 1 |
| Chow, EP | 1 |
| Wang, Y | 1 |
| Wilson, DP | 1 |
| Yen, YF | 1 |
| Yen, MY | 1 |
| Su, LW | 1 |
| Li, LH | 1 |
| Chuang, P | 1 |
| Jiang, XR | 1 |
| Deng, CY | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Prospective, Single Arm, Open-label 96 Week Observational Trial of the Tolerability, Adherence and Efficacy of a Dolutegravir/Abacavir/Lamivudine Single Tablet Regimen in HIV-1 Antibody Positive People Living With HIV With a History of Injection Drug Us[NCT02659761] | Phase 4 | 50 participants (Anticipated) | Interventional | 2016-11-30 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for methadone and Co-infection
| Article | Year |
|---|---|
Drug-Drug Interactions With Antiviral Agents in People Who Inject Drugs Requiring Substitution Therapy.
Topics: Analgesics, Opioid; Antiviral Agents; Coinfection; Drug Interactions; Hepatitis C; HIV Infections; H | 2015 |
HIV and HCV prevalence among entrants to methadone maintenance treatment clinics in China: a systematic review and meta-analysis.
Topics: China; Coinfection; Hepatitis C; HIV Infections; Methadone; Opiate Substitution Treatment; Prevalenc | 2012 |
1 trial available for methadone and Co-infection
| Article | Year |
|---|---|
Cost-effectiveness of hepatitis C screening and treatment linkage intervention in US methadone maintenance treatment programs.
Topics: Adult; Antiviral Agents; Coinfection; Cost-Benefit Analysis; Female; Hepatitis C, Chronic; Humans; M | 2018 |
15 other studies available for methadone and Co-infection
| Article | Year |
|---|---|
HCV treatment in Sardinian HIV-HCV coinfected patients: a real-life perspective study on safety, efficacy, and immune reconstitution.
Topics: Antiviral Agents; Coinfection; Female; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Im | 2022 |
HIV And HCV infection among opiate-dependent patients and methadone doses: the PROTEUS study.
Topics: Adult; Analgesics, Opioid; Anti-Retroviral Agents; Coinfection; Comorbidity; Dose-Response Relations | 2017 |
Trends and factors in human immunodeficiency virus and/or hepatitis C virus testing and infection among injection drug users newly entering methadone maintenance treatment in Guangdong Province, China 2006-2013: a consecutive cross sectional study.
Topics: Adolescent; Adult; China; Coinfection; Cross-Sectional Studies; Female; Hepatitis C; Hepatitis C Ant | 2017 |
Spatial distribution of HIV, HCV, and co-infections among drug users in the southwestern border areas of China (2004-2014): a cohort study of a national methadone maintenance treatment program.
Topics: Adult; China; Cohort Studies; Coinfection; Drug Users; Female; Hepatitis C; HIV Infections; Humans; | 2017 |
[TB/HIV co-infection associated with Kaposi's sarcoma under opioid substitution treatment using methadone: about a case].
Topics: AIDS-Related Opportunistic Infections; Coinfection; Female; Heroin Dependence; HIV Infections; Human | 2017 |
Methadone treatment, severe food insecurity, and HIV-HCV co-infection: A propensity score matching analysis.
Topics: Adult; Analgesics, Opioid; Canada; Cohort Studies; Coinfection; Female; Food Supply; Hepatitis C; HI | 2018 |
Prevalence of and risk factors for hepatitis C virus antibody among people who inject drugs in Cambodia: a national biological and behavioral survey.
Topics: Adult; Age Factors; Analgesics, Opioid; Antiviral Agents; Cambodia; Coinfection; Ethnicity; Female; | 2019 |
High prevalence of HIV, HCV and tuberculosis and associated risk behaviours among new entrants of methadone maintenance treatment clinics in Guangdong Province, China.
Topics: Adult; Analgesics, Opioid; China; Coinfection; Comorbidity; Female; Hepatitis C; HIV Infections; Hum | 2013 |
Incidence of hepatitis C infection among prisoners by routine laboratory values during a 20-year period.
Topics: Adult; Analgesics, Opioid; Coinfection; Follow-Up Studies; Hepacivirus; Hepatitis C; Hepatitis C Ant | 2014 |
The geographic distribution patterns of HIV-, HCV- and co-infections among drug users in a national methadone maintenance treatment program in Southwest China.
Topics: Adult; China; Coinfection; Drug Users; Female; Geography, Medical; Hepatitis C; HIV Infections; Huma | 2014 |
Hepatitis C virus infection and pain sensitivity in patients on methadone or buprenorphine maintenance therapy for opioid use disorders.
Topics: Adult; Buprenorphine; Case-Control Studies; Coinfection; Female; Hepatitis C; HIV Infections; Humans | 2015 |
Simeprevir-induced severe withdrawal syndrome in an HIV/HCV coinfected patient on long-term maintenance methadone therapy.
Topics: Antiretroviral Therapy, Highly Active; Antiviral Agents; Coinfection; Drug Interactions; Hepatitis C | 2015 |
[Prevalence of HIV and HCV infections in patients receiving methadone maintenance treatment in Kaiyuan, Yunnan].
Topics: China; Coinfection; Drug Users; Hepatitis C; HIV Infections; Humans; Methadone; Opiate Substitution | 2015 |
Hepatitis C in a Mobile Low-Threshold Methadone Program.
Topics: Adult; Aged; Alcohol-Related Disorders; Coinfection; Comorbidity; Cross-Sectional Studies; Drug User | 2017 |
Prevalences and associated risk factors of HCV/HIV co-infection and HCV mono-infection among injecting drug users in a methadone maintenance treatment program in Taipei, Taiwan.
Topics: Adult; Coinfection; Cross-Sectional Studies; Dose-Response Relationship, Drug; Female; Hepatitis C; | 2012 |